Bacteriophages targeting Acinetobacter baumannii capsule induce antimicrobial resensitization

Author:

Altamirano Fernando GordilloORCID,Forsyth John H.,Patwa Ruzeen,Kostoulias Xenia,Trim Michael,Subedi DineshORCID,Archer Stuart,Morris Faye C.ORCID,Oliveira Cody,Kielty Luisa,Korneev DenisORCID,O’Bryan Moira K.ORCID,Lithgow Trevor J.ORCID,Peleg Anton Y.ORCID,Barr Jeremy J.ORCID

Abstract

AbstractCarbapenem-resistant Acinetobacter baumannii is responsible for frequent, hard-to-treat and often fatal healthcare-associated infections. Phage therapy, the use of viruses that infect and kill bacteria, is an approach gaining significant clinical interest to combat antibiotic-resistant infections. However, a major limitation is that bacteria can develop resistance against phages. Here, we isolated phages with activity against a panel of A. baumannii strains and focused on clinical isolates AB900 and A9844 and their phages for detailed characterization. As expected, coincubation of the phages with their hosts in vitro resulted in the emergence of phage-resistant bacterial mutants. Genome sequence analysis revealed that phage-resistant mutants harbored loss-of-function mutations in genes from the K locus, responsible for the biosynthesis of the bacterial capsule. Using molecular biology techniques, phage adsorption assays, and quantitative evaluation of capsule production, we established that the bacterial capsule serves as the primary receptor for these phages. As a collateral phenotype of impaired capsule production, the phage-resistant strains could not form biofilms, became fully sensitized to the human complement system, showed increased susceptibility to beta-lactam antibiotics, and became vulnerable to additional phages. Finally, in a murine model of bacteremia, the phage-resistant A. baumannii demonstrated a diminished capacity to colonize blood and solid tissues. This study demonstrates that phages can be used not only for their lytic activity but, if combined with a posteriori knowledge of their receptors and the mechanism of bacterial resistance, for their potential synergy with other antimicrobial agents, thus providing even broader clinical options for phage therapy.

Publisher

Cold Spring Harbor Laboratory

Reference80 articles.

1. World Health Organization. Ten threats to global health in 2019 [internet]. Geneva: World Health Organization; 2019 [cited 11 January 2020] Available from: https://www.who.int/emergencies/ten-threats-to-global-health-in-2019.

2. The Relationship between Antimicrobial Resistance and Patient Outcomes: Mortality, Length of Hospital Stay, and Health Care Costs

3. Estimating the burden of antimicrobial resistance: a systematic literature review

4. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States [internet]. Atlanta, GA, USA: Department of Health and Human Services CDC; 2019 [cited 11 January 2020] Available from: https://www.cdc.gov/drugresistance/Biggest-Threats.html

5. World Health Organization. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics [internet]. Geneva: World Health Organization; 2017 p. 5. Available from: https://www.who.int/medicines/publications/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3